Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chymase (Homo sapiens (Human)) | BDBM337803 (2,4-Dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337774 (1-[3,5-Dichloro-4-(2-oxoimidazolidin-1-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337767 (1-[3-Chloro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-[2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337796 (1-[2-Fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337766 (1-[3-Chloro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-[2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337759 (1-[3-Chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337773 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[3,5-dich...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337758 (1-[3-Chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337793 (2,4-Dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337755 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337788 (1-(3,4-Dimethoxyphenyl)-2,4-dioxo-3-[4-(trifluorom...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337770 (3-[2,3-Bis(trifluoromethyl)benzyl]-2,4-dioxo-1-[4-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337690 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337720 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337802 (Ethyl 2,4-dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337789 (3-[2,3-Bis(trifluoromethyl)benzyl]-1-(3,4-dimethox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337683 (1-[3-Fluoro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-[2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337708 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337764 (1-[2-Fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337761 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[3-methyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337805 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337765 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[3,5-dich...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337760 (1-[3-Methyl-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337739 (Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337801 (3-(5-Chloro-1,2,3,4-tetrahydronaphthalen-1-yl)-2,4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337676 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337747 (Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-1-[3,...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337748 (Ethyl 1-[3,5-dichloro-4-(2-oxoimidazolidin-1-yl)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337798 (2,4-Dioxo-1-[4-(2-oxoimidazolidin-1-yl)phenyl]-3-[...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337709 (3-(3-Chloro-2-nitrobenzyl)-2,4-dioxo-1-[4-(2-oxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337762 (3-(2,3-Dichlorobenzyl)-1-[2-fluoro-4-(2-oxo-1,3-ox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337791 (3-(4-Chloro-2,3-dihydro-1H-inden-1-yl)-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337694 (1-(3,4-Dimethoxyphenyl)-3-[2-methyl-3-(trifluorome...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337763 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[2-fluoro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337769 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[2-methyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337689 (3-[3-Fluoro-2-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337757 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337768 (1-[2-Methyl-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337699 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 61 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337795 (Ethyl 1-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337785 (3-(3-Chloro-2-methylbenzyl)-2,4-dioxo-1-[4-(2-oxo-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337790 (3-(4-Chloro-2,3-dihydro-1H-inden-1-yl)-1-(3,4-dime...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337794 (1-[3-Chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337682 (1-[3-Fluoro-4-(2-oxoimidazolidin-1-yl)phenyl]-3-(2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337685 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxo-2,3-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337777 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337743 (Ethyl 1-[2-fluoro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337688 (3-(2-Methyl-3-nitrobenzyl)-2,4-dioxo-1-[4-(2-oxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337734 (3-[(3-Chloro-4-methyl-2-thienyl)methyl]-2,4-dioxo-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337742 (Ethyl 1-[3-chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337674 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-(4-methox...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337651 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337715 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337775 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337753 (Ethyl 2,4-dioxo-1-[4-(2-oxo-1,3-oxazolidin-3-yl)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337745 (Ethyl 1-[3-chloro-4-(2-oxoimidazolidin-1-yl)phenyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337782 (3-(3-Chloro-2-methylbenzyl)-1-(3,4-dimethoxyphenyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337691 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxo-1,3-o...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337800 (Ethyl 3-(5-chloro-1,2,3,4-tetrahydronaphthalen-1-y...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337804 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(4-oxoimidaz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337704 (1-[3,5-Difluoro-4-(2-oxoimidazolidin-1-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337703 (3-(2-Chloro-3-(trifluoromethyl)benzyl)-1-[3,5-difl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 97 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337678 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxoimidaz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 98 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337713 (1-(3-Fluoro-4-{[(2-methoxyethyl)carbamoyl]amino}ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 99 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337701 (1-[3,5-Difluoro-4-(2-oxoimidazolidin-1-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 106 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337669 (Ethyl 1-(3,4-dimethoxyphenyl)-3-[2-methyl-3-(trifl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 109 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337681 (3-(2,3-Dichlorobenzyl)-1-[3-fluoro-4-(2-oxoimidazo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337771 (3-[3-(Difluoromethyl)-2-methylbenzyl]-1-(3,4-dimet...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337735 (3-[(3-Chloro-4-methyl-2-thienyl)methyl]-1-(3,4-dim...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337797 (Ethyl 2,4-dioxo-1-[4-(2-oxoimidazolidin-1-yl)pheny...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337714 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(3-oxomorpho...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 127 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337783 (1-(3,4-Dimethoxyphenyl)-3-(3-fluoro-2-methylbenzyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 128 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337711 (1-[4-(2-Amino-2-oxoethoxy)phenyl]-3-(2-methyl-3-ni...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 133 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337677 (3-(2,3-Dimethylbenzyl)-2,4-dioxo-1-[4-(2-oxoimidaz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 138 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337744 (Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-1-[3,...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337712 (1-[4-(2-Amino-2-oxoethoxy)phenyl]-3-(2,3-dichlorob...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 143 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337687 (3-[3-Fluoro-2-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 145 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337731 (1-[4-(5-Amino-1,3,4-oxadiazol-2-yl)phenyl]-3-[2-ch...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 151 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337741 (Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337779 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[4-(4-met...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337756 (1-{4-[(5S)-5-(Acetamidomethyl)-2-oxo-1,3-oxazolidi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337650 (Ethyl 3-[3-fluoro-2-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 171 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337653 (Ethyl 1-[3-fluoro-4-(2-oxoimidazolidin-1-yl)phenyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 171 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337717 (1-[4-(2-Hydroxyethoxy)phenyl]-3-[2-methyl-3-(trifl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 176 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337786 (3-(4-Methyl-2,3-dihydro-1H-inden-1-yl)-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337646 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 186 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337656 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 189 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337658 (Ethyl 1-[3,5-difluoro-4-(2-oxoimidazolidin-1-yl)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 205 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337667 (Ethyl 3-(2-methyl-3-nitrobenzyl)-2,4-dioxo-1-[4-(2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 207 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337799 (1-{4-[(Methoxycarbonyl)amino]phenyl}-3-[2-methyl-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337700 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxo-1,3-o...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337732 (1-[4-(5-Amino-1,3,4-oxadiazol-2-yl)phenyl]-3-[2-me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 213 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337684 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 217 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337754 (Ethyl 1-[3-chloro-4-(2-oxo-1,3-oxazolidin-3-yl)phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337680 (3-[3-Fluoro-2-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 222 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337696 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 225 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337672 (1-[4-(Methylsulfinyl)phenyl]-2,4-dioxo-3-[3-(trifl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 227 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337727 (1-[4-(4-Methyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337746 (Ethyl 1-[2-methyl-4-(2-oxo-1,3-oxazolidin-3-yl)phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337718 (1-{4-[(2-Hydroxyethyl)amino]phenyl}-3-[2-methyl-3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 231 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337781 (1-{4-[(Methoxycarbonyl)(methyl)amino]phenyl}-3-[2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337671 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 241 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337693 (1-(4-Methoxyphenyl)-3-[2-methyl-3-(trifluoromethyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 252 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337792 (3-[3-Chloro-2-(trifluoromethyl)benzyl]-1-[4-(3,5-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337652 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 263 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337668 (Ethyl 3-[3-fluoro-2-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 271 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337649 (Ethyl 3-(2,3-dichlorobenzyl)-2,4-dioxo-1-[4-(4-oxo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 279 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337695 (1-(4-Ethoxyphenyl)-3-[3-fluoro-2-(trifluoromethyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 289 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337660 (Ethyl 3-(2-chloro-3-(trifluoromethyl)benzyl)-1-[3,...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337787 (3-(2-Chloro-3,6-difluorobenzyl)-2,4-dioxo-1-[4-(2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337733 (1-[4-(5-Amino-1,3,4-oxadiazol-2-yl)phenyl]-3-(2,3-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 297 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337706 (3-[3-Chloro-2-(methylsulfanyl)benzyl]-1-(3,4-dimet...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 297 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337749 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337647 (Ethyl 3-(2,3-dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 348 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337705 (3-(2-Chloro-3-methylbenzyl)-1-[3,5-difluoro-4-(2-o...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 362 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337716 (1-[4-(2-Hydroxyethoxy)phenyl]-3-(2-methyl-3-nitrob...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 368 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337778 (3-[2-Chloro-3-(trifluoromethyl)benzyl]-1-[4-(3-met...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337719 (1-{4-[4-(Hydroxymethyl)-1H-1,2,3-triazol-1-yl]phen...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 392 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337673 (Ethyl 1-[4-(1,1-dioxido-1,2,5-thiadiazolidin-2-yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 396 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337784 (1-(3,4-Dimethoxyphenyl)-2,4-dioxo-3-{1-[3-(trifluo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337679 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxotetrah...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 419 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337675 (3-(2,3-Dichlorobenzyl)-1-(4-methoxyphenyl)-2,4-dio...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 423 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337697 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(1H-pyrazol-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 427 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337686 (3-(2,3-Dichlorobenzyl)-2,4-dioxo-1-[4-(2-oxopyrrol...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 433 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337655 (Ethyl 3-(2,3-dichlorobenzyl)-1-[3-fluoro-4-(2-oxoi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 435 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337780 (1-[4-(4,4-Dimethyl-2-oxoimidazolidin-1-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337772 (3-(2,3-Dihydro-1H-inden-1-yl)-1-(3,4-dimethoxyphen...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337730 (Ethyl 3-[(3-chloro-4-methyl-2-thienyl)methyl]-1-(3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337648 (Ethyl 3-(2,3-dimethylbenzyl)-2,4-dioxo-1-[4-(2-oxo...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 522 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337740 (Ethyl 1-{4-[(5S)-5-(acetamidomethyl)-2-oxo-1,3-oxa...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337729 (Ethyl 3-[(3-chloro-4-methyl-2-thienyl)methyl]-2,4-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 560 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337750 (Ethyl 3-[2-chloro-3-(trifluoromethyl)benzyl]-1-[4-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 560 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337722 (Ethyl 1-[4-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 580 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337654 (Ethyl 1-[3-fluoro-4-(2-oxoimidazolidin-1-yl)phenyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 591 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337662 (Ethyl 1-[3,5-difluoro-4-(2-oxoimidazolidin-1-yl)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 593 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337659 (Ethyl 3-(2,3-dichlorobenzyl)-1-[3,5-difluoro-4-(2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 625 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337752 (Ethyl 1-{4-[(methoxycarbonyl)(methyl)amino]phenyl}...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337698 (3-[3-Fluoro-2-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 632 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337702 (3-(2,3-Dichlorobenzyl)-1-[3,5-difluoro-4-(2-oxoimi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 642 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337738 (1-[4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-3-[2-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 680 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337721 (Ethyl 1-[4-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337736 (1-[4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-3-[2-c...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 815 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337726 (Ethyl 3-[2-methyl-3-(trifluoromethyl)benzyl]-2,4-d...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337728 (3-[2-Methyl-3-(trifluoromethyl)benzyl]-2,4-dioxo-1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337751 (Ethyl 1-[4-(4,4-dimethyl-2-oxoimidazolidin-1-yl)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337724 (Ethyl 1-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337723 (Ethyl 1-[4-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-3...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Chymase (Homo sapiens (Human)) | BDBM337725 (Ethyl 1-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description The enzyme source used is recombinant human chymase (expressed in HEK293 cells) or chymase purified from hamsters' tongues. The substrate used fo... | US Patent US9751843 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
